Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/1992
06/24/1992EP0403503A4 Nucleic acid isolation
06/24/1992EP0207963B1 Monoclonal antibodies and antigen for human non-small cell lung carcinomas
06/24/1992CN1062172A Ribosome-inactivating proteins, inactive precursor forms thereof, process for making and method of using
06/24/1992CN1062170A Method for expressing outside source gene by domestic silkworm larva chrysalis
06/24/1992CN1062169A Pichia pastoris acid phosphatae gene
06/24/1992CN1062168A Chicken anemia virus vaccine and diagnostic
06/23/1992WO1992011362A1 Serotonine receptor of class 1: the 5-ht1x receptors
06/23/1992US5124504 Nitrate-tolerant soybean
06/23/1992US5124440 Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus
06/23/1992US5124264 Monoclonal antibody recognizing atrial natriuretic polypeptide
06/23/1992US5124263 Recombination resistant retroviral helper cell and products produced thereby
06/23/1992US5124261 Using genetic engineering technique comprising heat treating a host cell having the aqualysin precursor in a culture medium, and recovering the aqualysin
06/23/1992US5124260 Directs stable integration of DNA segment or selectable marker to defined nonessential site
06/23/1992US5124259 Suspenion of cells and Dna in potassium salt of (amino)acids; applying voltage
06/23/1992US5124257 Method for preparing l-alanine
06/23/1992US5124255 CKS method of protein synthesis
06/23/1992US5124248 Medical diagnosis; immunoassay
06/23/1992US5124153 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
06/23/1992CA2098706A1 5-ht1x receptor
06/23/1992CA1304026C Vector and method for achieving high level expression in eukaryotic cells
06/23/1992CA1304025C Modified zein
06/23/1992CA1304024C Covalently linked polypeptide cell modulators
06/23/1992CA1304023C .beta.-UROGASTRONE GENE, CORRESPONDING RECOMBINANT PLASMIDS, CORRESPONDING TRANSFORMANTS AND PREPARATION THEREOF AND OF .beta.-UROGASTRONE
06/23/1992CA1304022C Insulin precursors, process for their preparation and process for preparing human insulin from such insulin precursors
06/23/1992CA1304021C Microbiological process for the preparation of a protein by culturing a mutant bacterial strain
06/23/1992CA1304020C High level expression in yeast
06/22/1992WO1992011387A1 Diagnosis for porcine malignant hyperthermia
06/22/1992WO1992011374A1 DNA SEQUENCES ENCODING AT LEAST PART OF THE TOMATO ENZYME ENDOPOLYGALACTURONASE PG1 β-SUBUNIT
06/22/1992WO1992011364A1 Biosynthetic pdgf antagonists
06/22/1992WO1992011348A1 Enzymes and enzymatic detergent compositions
06/22/1992WO1992011286A1 Oxidation resistant variants of parathyroid hormone
06/22/1992CA2098837A1 Dna sequences encoding at least part of the tomato enzyme endopolygalacturonase pg1 .beta.-subunit
06/22/1992CA2098703A1 Enzymes and enzymatic detergent compositions
06/22/1992CA2098283A1 Oxidation resistant variants of parathyroid hormone
06/22/1992CA2097603A1 Biosynthetic pdgf antagonists
06/22/1992CA2079702A1 Diagnosis for porcine malignant hyperthermia
06/22/1992CA2058379A1 Babesial protease antigen
06/22/1992CA2058280A1 Expression systems
06/21/1992WO1992011273A1 Pcr primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
06/21/1992WO1992011272A1 Optimization of binding proteins
06/21/1992WO1992011120A1 Method and apparatus for granulation
06/21/1992CA2098824A1 Optimization of binding proteins
06/21/1992CA2098600A1 Method and apparatus for granulation
06/21/1992CA2075493A1 Pcr primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
06/20/1992WO1992011378A1 A method of constructing synthetic leader sequences
06/20/1992WO1992011018A1 Improved humanized immunoglobulins
06/20/1992CA2098731A1 Method of constructing synthetic leader sequences
06/20/1992CA2057715A1 Method for enhancing the structural stability of recombinant dna expression vectors
06/19/1992WO1992011377A1 Tissue plasminogen activator substitution variant
06/19/1992WO1992011360A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity
06/19/1992CA2098484A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity
06/19/1992CA2057951A1 Chimeric antibodies and their use
06/19/1992CA2057842A1 Human monoclonal antibody
06/17/1992EP0490410A1 TXA2 Receptor and gene encoding the same
06/17/1992EP0490233A1 Monoclonal antibodies against Bgl III-hybrid interferons, their use and process for preparing them
06/17/1992EP0490077A1 Antisense oligonucleotides for treatment of cancer
06/17/1992EP0489868A1 Transgenic animal model for viral infections
06/17/1992EP0489846A1 Antisense oligonucleotides to c-abl proto-oncogene
06/17/1992EP0489830A1 Expression of alpha-macroglobulins
06/17/1992EP0489822A1 Abo genotyping
06/17/1992EP0489780A1 Fusion proteins, their preparation and use
06/17/1992EP0485608A4 Method for obtaining polypeptides in a cell-free translation system
06/17/1992EP0484411A4 Prevention of internal initiation
06/17/1992EP0479922A4 Monoclonal antibodies to c-reactive protein
06/17/1992EP0467953A4 Improved primer extension reactions
06/17/1992EP0215131B1 E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
06/17/1992DE4105374C1 New hybridoma Han-41 and its corresp. antibody - recognise glyco-protein found in broncho-alveolar system; useful as cell differentiation markers and to classify human lung
06/17/1992DE4040043A1 New acid-stable and infectious human rhinovirus mutant - prepd. by incubating wild type virus at varying pH, useful for treating rhinoviral infection
06/17/1992CN1062002A Protease
06/17/1992CN1062001A Silkworm method for efficient expressing protein of chinese trichosanthes root and other useful proteins
06/16/1992US5122600 Using a carrier of specific particle size and one which does not absorb protein
06/16/1992US5122599 CDNAS coding for members of the carcinoembryonic antigen family
06/16/1992US5122595 Modulates expression of extracellular enzymes in Streptomyces
06/16/1992US5122594 Having specific arginines replaced by glutamine and/or serine
06/16/1992US5122466 Ballistic transformation of conifers
06/16/1992US5122465 Strains of pichia pastoris created by interlocus recombination
06/16/1992US5122464 Method for dominant selection in eucaryotic cells
06/16/1992US5122463 Methods for trans-destabilization of specific proteins in vivo and dna molecules useful therefor
06/16/1992US5122459 Gene encoding biologically active human interleukin 1
06/16/1992US5122458 Use of a bgh gdna polyadenylation signal in expression of non-bgh polypeptides in higher eukaryotic cells
06/16/1992US5122457 Expression systems utilizing bacteriophage t7 promoters, gene sequences, and t7 rna polymerase
06/16/1992CA1303534C Human anti-rh(d) monoclonal antibodies
06/16/1992CA1303533C Human anti-rh(d) monoclonal antibodies
06/16/1992CA1303532C Determination of fibrin using fibrin-specific antibodies
06/16/1992CA1303531C Choriocarcinoma monoclonal antibodies and antibody panels
06/16/1992CA1303530C EXPRESSION VECTORS AND THEIR USE FOR THE PREPARATION OF A PROTEIN HAVING HUMAN .alpha. -ANTITRYPSIN ACTIVITY
06/16/1992CA1303529C Human interferon- _polypeptide derivative
06/16/1992CA1303527C Cross-over linker dna sequence
06/16/1992CA1303525C Rotavirus reassortant vaccine
06/15/1992WO1992010506A1 Human retrovirus receptor and dna coding therefor
06/15/1992CA2097705A1 Human retrovirus receptor and dna coding therefor
06/14/1992WO1992010577A1 Multisite integration cassette for the genome of a yeast
06/14/1992WO1992010576A1 Fusion polypeptides
06/14/1992WO1992010570A1 Leukemia inhibitory factor receptors
06/14/1992WO1992010564A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
06/14/1992CA2098510A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
06/14/1992CA2098304A1 Multisite integration cassette for the genome of a yeast
06/14/1992CA2097291A1 Leukemia inhibitory factor receptors
06/14/1992CA2094512A1 Fusion polypeptides
06/11/1992WO1992010582A1 Monokine mig induced by ifn-gamma